BE CAR-7

N/A

Report date: 2023/08/10 18:03:17

Base Information

Drug NameBE CAR-7

Drug Alias NameBECAR7Cryopreserved BE CAR7 T cells therapy (BE752TBCCLCAR7PBL)Base Edited CAR7 T CellsTvT CAR7Base Edited CAR7 T cells Therapy +[6]

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT-cell antigen CD7 inhibitors

TargetsT-cell antigen CD7

Therapy Area/IndicationsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Prolymphocytic, T-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesGreat Ormond Street Hospital For Children Nhs Foundation Trust

China Registration ClassN/A

Develop Information

Active CompaniesGreat Ormond Street Hospital For Children Nhs Foundation Trust

Inactive CompaniesN/A

Active IndicationsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaLeukemia, Prolymphocytic, T-Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A